Outlook Therapeutics, Inc. Common Stock (OTLK)

Typically moves ±6.14% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-12-15 ESTIMATED
search

Since May 14, 2021, Outlook Therapeutics, Inc. Common Stock (OTLK) has reported earnings 23 times. On average the shares move ±6.14% post-earnings, with a positive reaction 47.8% of the time. Its largest post-earnings gain was +17.54% (Dec 27, 2024) and its largest decline was -19.95% (Aug 12, 2026). The next earnings report is predicted for 2026-12-15 (estimated).

Earnings reactions

How OTLK moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

23

Avg Abs. Movement

±6.14%

Positive %

47.8%

Negative %

52.2%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 14, 2026 ☀ PRE -14.87% open_in_new
Aug 12, 2026 ☽ POST -19.95% open_in_new
May 18, 2026 ☽ POST -0.39% open_in_new
Feb 17, 2026 ☀ PRE -14.67% open_in_new
event

Earnings Count

23

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.14%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 15 →
15
Funds holding
$4895594
Total value held
Buying
12 added · 2 reduced
Blackrock, Inc.
$2653040 +249.46%
State Street Corp
$858285 +230.96%
Raymond James Financial Inc
$527961 +1127.50%
Northern Trust Corp
$377722 +252.52%
Ubs Group Ag
$242022 NEW BUY

Frequently asked about OTLK earnings

When does Outlook Therapeutics, Inc. Common Stock report earnings next? expand_more

Outlook Therapeutics, Inc. Common Stock (OTLK)'s next earnings date is estimated for 2026-12-15. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does OTLK stock move after earnings? expand_more

Over 23 reports, OTLK has moved an average of ±6.14% the session after earnings, closing higher 47.8% of the time.

What was OTLK's biggest post-earnings move? expand_more

OTLK's largest post-earnings gain on record was +17.54% on Dec 27, 2024, and its largest decline was -19.95% on Aug 12, 2026.

Where can I find Outlook Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Outlook Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.